drug development

Advertisement

cGxPJobs Banner

.Clinical Bio-Pharma

CorrectSequence Therapeutics Promising Results for World’s First Cure of Sickle Cell via transformer Base Editing

Shanghai, China, August 26, 2025 – In a landmark advancement, CorrectSequence Therapeutics Co., Ltd. (Correctseq) has announced the first...

By cGxPwire Editor
August 26, 2025

Read More

.Clinical Bio-Pharma

Sanofi’s Rilzabrutinib Gets EU Orphan Drug Status for IgG4-Related Disease

Paris, August 14, 2025 – The European Medicines Agency (EMA) has granted orphan drug designation to Sanofi’s rilzabrutinib, a...

By cGxPwire Editor
August 26, 2025

Read More

BridgeBio Secures $300 Million Upfront Through Royalty Monetization of BEYONTTRA in Europe

PALO ALTO, CA., June 30, 2025 — BridgeBio Pharma, Inc. (Nasdaq: BBIO), the biopharmaceutical company dedicated to developing transformative...

By cGxPwire Editor
August 25, 2025

Read More

Advertisement

cGxPJobs

Directory